Clinical Trial: Serum 25-Hydroxyvitamin D and Neurological Disability in Multiple Sclerosis

U.S., Aug. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07123337) titled 'Serum 25-Hydroxyvitamin D and Neurological Disability in Multiple Sclerosis' on Aug. 07.

Brief Summary: Vitamin D is hypothesized to play a role in the immunopathology and progression of multiple sclerosis (MS), yet its association with neurological disability remains uncertain, particularly in North African populations.We conducted a cross-sectional study involving 369 adult MS patients across two tertiary neurology centers in Western Libya. Serum 25-hydroxyvitamin D [25(OH)D] levels and Expanded Disability Status Scale (EDSS) scores were collected. Pearson correlation, ANOVA, and multivariable linear regression were used to assess...